CVE-2022-45611

EUVD-2022-48475
An issue was discovered in Fresenius Kabi PharmaHelp 5.1.759.0 allows attackers to gain escalated privileges via via capture of user login information.
ProviderTypeBase ScoreAtk. VectorAtk. ComplexityPriv. RequiredVector
NISTPrimary
9.8 CRITICAL
NETWORK
LOW
NONE
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
Base Score
CVSS 3.x
EPSS Score
Percentile: 36%
Affected Products (NVD)
VendorProductVersion
fresenius-kabipharmahelp_firmware
5.1.759.0
𝑥
= Vulnerable software versions
Common Weakness Enumeration
References
https://www.fresenius-kabi.com/de-at/produkte/pharmahelp-compounder
https://www.fresenius.com/sites/default/files/2023-11/Fresenius%20-%20CVE-2022-45611.pdf
https://www.fresenius.com/sites/default/files/2023-12/Fresenius%20-%20CVE-2022-45611.pdf
https://www.fresenius-kabi.com/de-at/produkte/pharmahelp-compounder
https://www.fresenius.com/sites/default/files/2023-11/Fresenius%20-%20CVE-2022-45611.pdf
https://www.fresenius.com/sites/default/files/2023-12/Fresenius%20-%20CVE-2022-45611.pdf